|
Age(years)
|
57.6 ± 7.6
|
61.8 ± 7.4
|
0.001
|
|
Male,n(%)
|
41(58.6)
|
39(50.0)
|
0.296
|
|
Current smoker, n (%)
|
17(24.3)
|
26(33.3)
|
0.226
|
|
Alcohol consumption, n (%)
|
15(21.4)
|
22(28.2)
|
0.342
|
|
Hypertension, n (%)
|
35(50.0)
|
46(59.0)
|
0.273
|
|
Use of β-Blockers
|
16(22.9)
|
18(23.1)
|
0.856
|
|
Use of ACEI/ARB
|
32(45.7)
|
35(44.9)
|
0.746
|
|
Use of CCB
|
22(31.4)
|
26(33.3)
|
0.246
|
|
Other antihypertensives
|
8(11.4)
|
6(7.7)
|
0.168
|
|
Duration of diabetes(years)*
|
6.0(2.0-10.3)
|
6.0(2.0-11.0)
|
0.815
|
|
BMI(kg/m2)
|
23.9 ± 3.1
|
25.0 ± 3.6
|
0.042
|
|
Waist-to-hip ratio*
|
0.94(0.88-0.99)
|
0.94(0.90-1.00)
|
0.849
|
|
systolic blood pressure(mmHg)
|
132.2 ± 16.4
|
136.0 ± 19.4
|
0.207
|
|
diastolic blood pressure(mmHg)
|
78.7 ± 11.0
|
78.0 ± 10.3
|
0.691
|
|
HbA1c(%)
|
7.9 ± 1.7
|
8.1 ± 2.0
|
0.613
|
|
fasting glucose(mmol/l)*
|
7.1(6.0-9.1)
|
6.7(5.8-9.3)
|
0.750
|
|
Creatinine (μmol/L)*
|
64.0(52.0-78.0)
|
59.0(53.0-79.5)
|
0.519
|
|
eGFR( ml/min/1.73 m2)
|
107.8 ± 25.4
|
103.0 ± 31.1
|
0.303
|
|
total cholesterol(mmol/l)
|
4.83 ± 1.92
|
4.94 ± 1.16
|
0.709
|
|
Triglyceride(mmol/l)*
|
1.54(0.99-2.69)
|
1.75(1.10-2.33)
|
0.510
|
|
LDL cholesterol(mmol/l)*
|
2.84(2.11-3.60)
|
2.83(2.37-3.60)
|
0.632
|
|
HDL cholesterol(mmol/l)*
|
1.10(0.92-1.30)
|
1.09(0.94-1.36)
|
0.693
|
|
ACR(mg/g)
|
10.90(6.87-24.72)
|
15.41(7.60-23.67)
|
0.472
|
|
baPWV(cm/sec)*
|
1584.0(1446.1-1812.63)
|
1722.0(1493.9-2040.8)
|
0.011
|
|
Diabetic retinopathy, n (%)
|
10(14.3)
|
15(19.2)
|
0.423
|
|
Diabetic peripheral neuropathy, n (%)
|
16(22.9)
|
30(38.5)
|
0.041
|
|
NSS score*
|
3.0(2.0-5.0)
|
5.0(3.0-6.0)
|
0.036
|
|
NDS score*
|
3.0(2.0-4.0)
|
4.0(2.0-5.0)
|
0.065
|
|
Diabetic nephropathy, n (%)
|
16(22.9)
|
17(21.8)
|
0.877
|
